Accuray Financial Restructuring
Accuray Secures Financial Restructuring and Board Changes to Fuel Future Growth Strategy
Key Points
Q4 service revenue rose 6% year over year to $60.1 million, signaling growing importance of Accuray's recurring revenue base.
For fiscal 2026, service revenue grew 4% for the year, underscoring momentum in the recurring portion of the business despite weaker product sales.
Backlog at June 30 stood at $312.5 million, with Q4 gross product orders of $37.7 million, highlighting a sizeable pipeline despite the quarterly revenue decline.
TCW will deleverage by exchanging $40 million of term loan for convertible preferred stock, with an 8% dividend and a $40 million liquidation preference; the preferred stock is convertible at $0.50 per share, representing about a 105.4% premium to the stock price as of July 28, 2026, and TCW will also invest $15 million in cash plus up to a $5 million delayed-draw loan.
Governance change: the board will be reduced to seven members, with TCW-designated Steven Mayer and Chan Galbato joining the board; Beverly Huss and Anne Le Grand stepped down from the board.
Accuray closed fiscal 2026 with a transformational year of cost cuts and margin improvements totaling over $20 million, though quarterly revenue fell 21% to $100.9 million TipRanks. The medical device company posted a $1.9 million net loss for the quarter and a $49.2 million loss for the full year, but strengthened its balance sheet through a major deal with TCW Asset Management that exchanges $40 million in debt for convertible preferred stock and includes $15 million in fresh cash Quiver Quant.
The restructuring signals Accuray's shift toward a stronger financial foundation. Service revenue, the company's recurring revenue base, grew 4% for the full year and rose 6% in Q4 to $60.1 million, offsetting weakness in product sales TipRanks. The backlog stood at $312.5 million as of June 30, suggesting a sizable pipeline ahead despite near-term headwinds.
TCW Deal Reshapes Balance Sheet and Board
TCW Asset Management will convert $40 million of term loan debt into convertible preferred stock carrying an 8% annual dividend and a $40 million liquidation preference ScanX. The stock converts at $0.50 per share, a 105.4% premium to Accuray's price as of July 28. TCW also commits $15 million in cash and up to $5 million in a delayed-draw loan to boost liquidity and reduce debt Yahoo Finance.
Governance shifts with the board shrinking to seven members. Two TCW-designated directors, Steven Mayer and Chan Galbato, join the board, while Beverly Huss and Anne Le Grand step down TipRanks. The changes reflect TCW's increased influence as Accuray accelerates its second phase focused on innovation and further cost reduction.
Service Revenue Momentum Offsets Product Sales Drop
Accuray's recurring revenue base is outpacing the company's overall performance. Service revenue grew 4% year-over-year for fiscal 2026 and jumped 6% in Q4 alone to $60.1 million TipRanks. This growing share of stable, predictable income helps cushion the impact of a 21% quarterly revenue decline driven by weaker product sales.
The backlog at $312.5 million signals future revenue potential despite current headwinds Quiver Quant. Q4 gross product orders reached $37.7 million, demonstrating customer demand in Accuray's pipeline even as near-term results lag. Management emphasized this foundation as key to returning to sustainable growth.
Cost Cuts and Margins Drive Operational Turnaround
Cost and margin improvements totaling more than $20 million in fiscal 2026 show aggressive operational discipline TipRanks. Gross margins expanded as the company reduced overhead and streamlined operations. Full-year revenue of $401.9 million reflects a tough year, but improving unit economics suggest Accuray is building a leaner, more profitable base for growth Quiver Quant.
CEO Steve LaNeve characterized fiscal 2026 as transformational, pointing to execution progress and strategic partnerships TipRanks. The company withheld formal fiscal 2027 guidance but framed its position as stronger and more flexible. Analyst sentiment remains cautious, citing weak near-term fundamentals and stock volatility, though insiders note the operational improvements as concrete achievements.
Sentiment
Mostly NegativePublishers
10
Articles
21
Reach
31
